Cargando…

A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics

PURPOSE: Skin cancer incidence is increasing among Hispanics, who experience worse outcomes than non-Hispanic Whites. Precision prevention incorporating genetic testing for (melanocortin-1 receptor) MC1R, a skin cancer susceptibility marker, may improve prevention behavior. EXPERIMENTAL DESIGN: Hisp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacson, John Charles A., Doyle, Scarlet H., Del Rio, Jocelyn, Forgas, Stephanie M., Carvajal, Rodrigo, Gonzalez-Calderon, Guillermo, Ramírez Feliciano, Adriana, Kim, Youngchul, Roetzheim, Richard G., Sutton, Steven K., Vadaparampil, Susan T., Soto-Torres, Brenda, Kanetsky, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286490/
https://www.ncbi.nlm.nih.gov/pubmed/35845857
http://dx.doi.org/10.1158/2767-9764.CRC-21-0114
_version_ 1784748023675355136
author Lacson, John Charles A.
Doyle, Scarlet H.
Del Rio, Jocelyn
Forgas, Stephanie M.
Carvajal, Rodrigo
Gonzalez-Calderon, Guillermo
Ramírez Feliciano, Adriana
Kim, Youngchul
Roetzheim, Richard G.
Sutton, Steven K.
Vadaparampil, Susan T.
Soto-Torres, Brenda
Kanetsky, Peter A.
author_facet Lacson, John Charles A.
Doyle, Scarlet H.
Del Rio, Jocelyn
Forgas, Stephanie M.
Carvajal, Rodrigo
Gonzalez-Calderon, Guillermo
Ramírez Feliciano, Adriana
Kim, Youngchul
Roetzheim, Richard G.
Sutton, Steven K.
Vadaparampil, Susan T.
Soto-Torres, Brenda
Kanetsky, Peter A.
author_sort Lacson, John Charles A.
collection PubMed
description PURPOSE: Skin cancer incidence is increasing among Hispanics, who experience worse outcomes than non-Hispanic Whites. Precision prevention incorporating genetic testing for (melanocortin-1 receptor) MC1R, a skin cancer susceptibility marker, may improve prevention behavior. EXPERIMENTAL DESIGN: Hispanic participants (n = 920) from Tampa, FL and Ponce, PR, were block-randomized within MC1R higher- and average-risk groups to precision prevention or generic prevention arms. We collected baseline information on demographics, family history of cancer, phenotypic characteristics, health literacy, health numeracy, and psychosocial measures. Participants reported weekday and weekend sun exposure (in hours), number of sunburns, frequency of five sun protection behaviors, intentional outdoor and indoor tanning, and skin examinations at baseline, 3 months, and 9 months. Participants also reported these outcomes for their eldest child ≤10 years old. RESULTS: Among MC1R higher-risk participants, precision prevention increased sunscreen use (OR = 1.74, P = 0.03) and receipt of a clinical skin exam (OR = 6.51, P = 0.0006); and it decreased weekday sun exposure hours (β = −0.94, P = 0.005) and improved sun protection behaviors (β = 0.93, P = 0.02) in their children. There were no significant intervention effects among MC1R average-risk participants. The intervention did not elevate participant cancer worry. We also identified moderators of the intervention effect among both average- and higher-risk participants. CONCLUSIONS: Receipt of MC1R precision prevention materials improved some skin cancer prevention behaviors among higher-risk participants and their children and did not result in reduced prevention activities among average-risk participants. Despite these encouraging findings, levels of sun protection behaviors remained suboptimal among participants, warranting more awareness and prevention campaigns targeted to Hispanics SIGNIFICANCE: Our results support a precision public health approach to reducing skin cancers among Hispanics, an underserved population in precision medicine, and may additionally improve preventive behaviors among their children.
format Online
Article
Text
id pubmed-9286490
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-92864902022-07-15 A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics Lacson, John Charles A. Doyle, Scarlet H. Del Rio, Jocelyn Forgas, Stephanie M. Carvajal, Rodrigo Gonzalez-Calderon, Guillermo Ramírez Feliciano, Adriana Kim, Youngchul Roetzheim, Richard G. Sutton, Steven K. Vadaparampil, Susan T. Soto-Torres, Brenda Kanetsky, Peter A. Cancer Res Commun Research Article PURPOSE: Skin cancer incidence is increasing among Hispanics, who experience worse outcomes than non-Hispanic Whites. Precision prevention incorporating genetic testing for (melanocortin-1 receptor) MC1R, a skin cancer susceptibility marker, may improve prevention behavior. EXPERIMENTAL DESIGN: Hispanic participants (n = 920) from Tampa, FL and Ponce, PR, were block-randomized within MC1R higher- and average-risk groups to precision prevention or generic prevention arms. We collected baseline information on demographics, family history of cancer, phenotypic characteristics, health literacy, health numeracy, and psychosocial measures. Participants reported weekday and weekend sun exposure (in hours), number of sunburns, frequency of five sun protection behaviors, intentional outdoor and indoor tanning, and skin examinations at baseline, 3 months, and 9 months. Participants also reported these outcomes for their eldest child ≤10 years old. RESULTS: Among MC1R higher-risk participants, precision prevention increased sunscreen use (OR = 1.74, P = 0.03) and receipt of a clinical skin exam (OR = 6.51, P = 0.0006); and it decreased weekday sun exposure hours (β = −0.94, P = 0.005) and improved sun protection behaviors (β = 0.93, P = 0.02) in their children. There were no significant intervention effects among MC1R average-risk participants. The intervention did not elevate participant cancer worry. We also identified moderators of the intervention effect among both average- and higher-risk participants. CONCLUSIONS: Receipt of MC1R precision prevention materials improved some skin cancer prevention behaviors among higher-risk participants and their children and did not result in reduced prevention activities among average-risk participants. Despite these encouraging findings, levels of sun protection behaviors remained suboptimal among participants, warranting more awareness and prevention campaigns targeted to Hispanics SIGNIFICANCE: Our results support a precision public health approach to reducing skin cancers among Hispanics, an underserved population in precision medicine, and may additionally improve preventive behaviors among their children. American Association for Cancer Research 2022-01-11 /pmc/articles/PMC9286490/ /pubmed/35845857 http://dx.doi.org/10.1158/2767-9764.CRC-21-0114 Text en © 2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
spellingShingle Research Article
Lacson, John Charles A.
Doyle, Scarlet H.
Del Rio, Jocelyn
Forgas, Stephanie M.
Carvajal, Rodrigo
Gonzalez-Calderon, Guillermo
Ramírez Feliciano, Adriana
Kim, Youngchul
Roetzheim, Richard G.
Sutton, Steven K.
Vadaparampil, Susan T.
Soto-Torres, Brenda
Kanetsky, Peter A.
A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
title A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
title_full A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
title_fullStr A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
title_full_unstemmed A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
title_short A Randomized Clinical Trial of Precision Prevention Materials Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention Activities Among Hispanics
title_sort randomized clinical trial of precision prevention materials incorporating mc1r genetic risk to improve skin cancer prevention activities among hispanics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286490/
https://www.ncbi.nlm.nih.gov/pubmed/35845857
http://dx.doi.org/10.1158/2767-9764.CRC-21-0114
work_keys_str_mv AT lacsonjohncharlesa arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT doylescarleth arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT delriojocelyn arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT forgasstephaniem arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT carvajalrodrigo arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT gonzalezcalderonguillermo arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT ramirezfelicianoadriana arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT kimyoungchul arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT roetzheimrichardg arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT suttonstevenk arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT vadaparampilsusant arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT sototorresbrenda arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT kanetskypetera arandomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT lacsonjohncharlesa randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT doylescarleth randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT delriojocelyn randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT forgasstephaniem randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT carvajalrodrigo randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT gonzalezcalderonguillermo randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT ramirezfelicianoadriana randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT kimyoungchul randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT roetzheimrichardg randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT suttonstevenk randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT vadaparampilsusant randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT sototorresbrenda randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics
AT kanetskypetera randomizedclinicaltrialofprecisionpreventionmaterialsincorporatingmc1rgeneticrisktoimproveskincancerpreventionactivitiesamonghispanics